Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Panbela Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q3 2021
- Shares held
- 988.4K
- −123.2K (−11.1%) vs. Q3 2021
- Total value
- $1.72M
- −$692.0K (−28.7%) vs. Q3 2021
- New holders
- 2
- 4 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 11 | $115.8K |
| Q3 2023 | 7 | $71.8K |
| Q2 2023 | 9 | $945.1K |
| Q1 2023 | 20 | $857.7K |
| Q4 2022 | 15 | $34.5K |
| Q3 2022 | 17 | $801.0K |
| Q2 2022 | 13 | $111.0K |
| Q1 2022 | 16 | $1.78M |
| Q4 2021 | 17 | $1.72M |
| Q3 2021 | 18 | $2.41M |
| Q2 2021 | 17 | $3.12M |
| Q1 2021 | 15 | $2.74M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Panbela Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 338,382 | $592.0K | 0.17% | 00.0% | Unchanged |
| Vanguard Group Inc | 228,401 | $396.0K | 0.00% | 00.0% | Unchanged |
| Murchinson Ltd. | 136,753 | $238.0K | 0.02% | −13,247−8.8% | Reduced |
| Fieldpoint Private Securities, LLC | 94,521 | $164.0K | 0.03% | −44,139−31.8% | Reduced |
| Brand Asset Management Group, Inc. | 57,144 | $99.0K | 0.04% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 34,018 | $60.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 30,154 | $52.0K | 0.00% | +795+2.7% | Added |
| Buckingham Strategic Wealth, LLC | 24,927 | $43.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 20,000 | $35.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12,501 | $22.0K | 0.00% | +5,701+83.8% | Added |
| Tower Research Capital LLC (TRC) | 4,374 | $7.00K | 0.00% | +1,884+75.7% | Added |
| Advisor Group Holdings, Inc. | 3,115 | $5.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,924 | $5.00K | 0.00% | +1,807+161.8% | Added |
| Northwestern Mutual Wealth Management Co | 633 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 500 | $1.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 72 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22 | $0 | 0.00% | +22 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −32,996−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −23,882−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,682−100.0% | Sold out |